{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:01:11Z","timestamp":1789002071933,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,27]],"date-time":"2018-05-27T00:00:00Z","timestamp":1527379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009240","name":"Sveriges Kommuner och Landsting","doi-asserted-by":"crossref","award":["SKL 08\/2254"],"award-info":[{"award-number":["SKL 08\/2254"]}],"id":[{"id":"10.13039\/501100009240","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Erica Lederhausen Foundation"},{"name":"Drug Therapeutics Committee of Stockholm County"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00228-018-2480-y","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T19:32:51Z","timestamp":1527363171000},"page":"1165-1173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs"],"prefix":"10.1007","volume":"74","author":[{"given":"Diana M","family":"Rydberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Mejyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"Loikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Schenck-Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"von Euler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rickard E","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,27]]},"reference":[{"key":"2480_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6904-7-9","volume":"7","author":"H Patel","year":"2007","unstructured":"Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, Majeed A (2007) Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol 7:9. \n                    https:\/\/doi.org\/10.1186\/1472-6904-7-9","journal-title":"BMC Clin Pharmacol"},{"issue":"7456","key":"2480_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456):15\u201319. \n                    https:\/\/doi.org\/10.1136\/bmj.329.7456.15","journal-title":"BMJ"},{"issue":"1","key":"2480_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/jwh.2005.14.19","volume":"14","author":"GD Anderson","year":"2005","unstructured":"Anderson GD (2005) Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Women\u2019s Health (Larchmt) 14(1):19\u201329. \n                    https:\/\/doi.org\/10.1089\/jwh.2005.14.19","journal-title":"J Women\u2019s Health (Larchmt)"},{"issue":"3","key":"2480_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12265-009-9114-9","volume":"2","author":"S Oertelt-Prigione","year":"2009","unstructured":"Oertelt-Prigione S, Regitz-Zagrosek V (2009) Gender aspects in cardiovascular pharmacology. J Cardiovasc Transl Res 2(3):258\u2013266. \n                    https:\/\/doi.org\/10.1007\/s12265-009-9114-9","journal-title":"J Cardiovasc Transl Res"},{"issue":"2","key":"2480_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","volume":"42","author":"JB Schwartz","year":"2003","unstructured":"Schwartz JB (2003) The influence of sex on pharmacokinetics. Clin Pharmacokinet 42(2):107\u2013121. \n                    https:\/\/doi.org\/10.2165\/00003088-200342020-00001","journal-title":"Clin Pharmacokinet"},{"key":"2480_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-642-30726-3_5","volume":"214","author":"I Spoletini","year":"2012","unstructured":"Spoletini I, Vitale C, Malorni W, Rosano GM (2012) Sex differences in drug effects: interaction with sex hormones in adult life. Handb Exp Pharmacol 214:91\u2013105. \n                    https:\/\/doi.org\/10.1007\/978-3-642-30726-3_5","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"2480_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1517\/17425255.4.4.413","volume":"4","author":"MJ Scandlyn","year":"2008","unstructured":"Scandlyn MJ, Stuart EC, Rosengren RJ (2008) Sex-specific differences in CYP450 isoforms in humans. Expert Opin Drug Metab Toxicol 4(4):413\u2013424","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"16","key":"2480_CR8","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/eurheartj\/ehi397","volume":"26","author":"N Jochmann","year":"2005","unstructured":"Jochmann N, Stangl K, Garbe E, Baumann G, Stangl V (2005) Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 26(16):1585\u20131595. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehi397","journal-title":"Eur Heart J"},{"issue":"9","key":"2480_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0002-9149(97)89205-3","volume":"77","author":"RA Kloner","year":"1996","unstructured":"Kloner RA, Sowers JR, DiBona GF, Gaffney M, Wein M (1996) Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol 77(9):713\u2013722","journal-title":"Am J Cardiol"},{"issue":"3","key":"2480_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/0002-9343(89)90293-3","volume":"86","author":"K Kroenke","year":"1989","unstructured":"Kroenke K, Mangelsdorff AD (1989) Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med 86(3):262\u2013266","journal-title":"Am J Med"},{"issue":"2","key":"2480_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00006842-199803000-00006","volume":"60","author":"K Kroenke","year":"1998","unstructured":"Kroenke K, Spitzer RL (1998) Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med 60(2):150\u2013155","journal-title":"Psychosom Med"},{"issue":"4","key":"2480_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1046\/j.1525-1497.2001.016004266.x","volume":"16","author":"AJ Barsky","year":"2001","unstructured":"Barsky AJ, Peekna HM, Borus JF (2001) Somatic symptom reporting in women and men. J Gen Intern Med 16(4):266\u2013275","journal-title":"J Gen Intern Med"},{"issue":"5","key":"2480_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1472-8206.2002.00100.x","volume":"16","author":"JL Montastruc","year":"2002","unstructured":"Montastruc JL, Lapeyre-Mestre M, Bagheri H, Fooladi A (2002) Gender differences in adverse drug reactions: analysis of spontaneous reports to a regional pharmacovigilance Centre in France. Fundam Clin Pharmacol 16(5):343\u2013346","journal-title":"Fundam Clin Pharmacol"},{"issue":"sup2","key":"2480_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/14740338.2016.1225720","volume":"15","author":"L Sportiello","year":"2016","unstructured":"Sportiello L, Rafaniello C, Sullo MG, Nica M, Scavone C, Bernardi FF, Colombo DM, Rossi F (2016) No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region. Expert Opin Drug Saf 15(sup2):101\u2013107. \n                    https:\/\/doi.org\/10.1080\/14740338.2016.1225720","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"2480_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","volume":"140","author":"JR Nebeker","year":"2004","unstructured":"Nebeker JR, Barach P, Samore MH (2004) Clarifying adverse drug events: a clinician\u2019s guide to terminology, documentation, and reporting. Ann Intern Med 140(10):795\u2013801","journal-title":"Ann Intern Med"},{"key":"2480_CR16","unstructured":"Inclusion\/exclusion criteria for the \u201cImportant Medical Events\u201d list. European Medicines Agency. Available via European Medicines Agency. \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Other\/2016\/08\/WC500212100.pdf\n                    \n                  . Accessed January 31 2018"},{"key":"2480_CR17","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2015. Oslo, 2014. \n                    http:\/\/www.whocc.no\/atc_ddd_publications\/guidelines\/"},{"issue":"7","key":"2480_CR18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M (2007) The new Swedish prescribed drug register\u2014opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16(7):726\u2013735. \n                    https:\/\/doi.org\/10.1002\/pds.1294","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"2480_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00228-013-1591-8","volume":"70","author":"DM Rydberg","year":"2014","unstructured":"Rydberg DM, Holm L, Mejyr S, Loikas D, Schenck-Gustafsson K, von Euler M, Wettermark B, Malmstrom RE (2014) Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment. Eur J Clin Pharmacol 70(1):117\u2013126. \n                    https:\/\/doi.org\/10.1007\/s00228-013-1591-8","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"2480_CR20","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","volume":"50","author":"G Onder","year":"2002","unstructured":"Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, Gambassi G (2002) Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the elderly (GIFA). J Am Geriatr Soc 50(12):1962\u20131968","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2480_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0008-6363(01)00479-5","volume":"53","author":"M Fischer","year":"2002","unstructured":"Fischer M, Baessler A, Schunkert H (2002) Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53(3):672\u2013677","journal-title":"Cardiovasc Res"},{"issue":"12","key":"2480_CR22","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/archinte.1989.00390120061012","volume":"149","author":"GR Gibson","year":"1989","unstructured":"Gibson GR (1989) Enalapril-induced cough. Arch Intern Med 149(12):2701\u20132703","journal-title":"Arch Intern Med"},{"issue":"1","key":"2480_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.1365-2125.1999.00855.x","volume":"47","author":"FJ Mackay","year":"1999","unstructured":"Mackay FJ, Pearce GL, Mann RD (1999) Cough and angiotensin II receptor antagonists: cause or confounding? Br J Clin Pharmacol 47(1):111\u2013114","journal-title":"Br J Clin Pharmacol"},{"key":"2480_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1159\/000336450","volume-title":"Handbook of Clinical Gender Medicine","author":"ACMD Mattison Faye","year":"2012","unstructured":"Mattison Faye ACMD (2012) Drug disposition and effect. In: Schenck-Gustafsson K, DeCola P, Pfaff DW, Pisetsky DS (eds) Handbook of Clinical Gender Medicine. Karger, Basel, pp 473\u2013479"},{"issue":"8789","key":"2480_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0140-6736(92)91694-4","volume":"339","author":"I Os","year":"1992","unstructured":"Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S (1992) Female sex as an important determinant of lisinopril-induced cough. Lancet 339(8789):372","journal-title":"Lancet"},{"issue":"7","key":"2480_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3109\/10641963.2015.1026040","volume":"37","author":"A Sato","year":"2015","unstructured":"Sato A, Fukuda S (2015) A prospective study of frequency and characteristics of cough during ACE inhibitor treatment. Clin Exp Hypertens 37(7):563\u2013568. \n                    https:\/\/doi.org\/10.3109\/10641963.2015.1026040","journal-title":"Clin Exp Hypertens"},{"issue":"6","key":"2480_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0895-4356(94)00231-E","volume":"48","author":"LE Visser","year":"1995","unstructured":"Visser LE, Stricker BH, van der Velden J, Paes AH, Bakker A (1995) Angiotensin converting enzyme inhibitor associated cough: a population-based case-control study. J Clin Epidemiol 48(6):851\u2013857","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2480_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1440-1843.1998.d01-7.x","volume":"3","author":"Y Kawakami","year":"1998","unstructured":"Kawakami Y, Munakata M, Yamaguchi E, Furuya K, Matsuda T (1998) Molecular studies of bronchial asthma, sarcoidosis and angiotensin converting enzyme inhibitor-induced cough. Respirology 3(1):45\u201349","journal-title":"Respirology"},{"issue":"9","key":"2480_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/FPC.0b013e328348c6db","volume":"21","author":"S Mas","year":"2011","unstructured":"Mas S, Gasso P, Alvarez S, Ortiz J, Sotoca JM, Francino A, Carne X, Lafuente A (2011) Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes. Pharmacogenet Genomics 21(9):531\u2013538. \n                    https:\/\/doi.org\/10.1097\/FPC.0b013e328348c6db","journal-title":"Pharmacogenet Genomics"},{"issue":"10","key":"2480_CR30","first-page":"935","volume":"40","author":"J Grikiniene","year":"2004","unstructured":"Grikiniene J, Volbekas V, Stakisaitis D (2004) Gender differences of sodium metabolism and hyponatremia as an adverse drug effect. Medicina 40(10):935\u2013942","journal-title":"Medicina"},{"issue":"1","key":"2480_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5049\/EBP.2010.8.1.51","volume":"8","author":"KS Hwang","year":"2010","unstructured":"Hwang KS, Kim GH (2010) Thiazide-induced hyponatremia. Electrolyte Blood Press 8(1):51\u201357. \n                    https:\/\/doi.org\/10.5049\/EBP.2010.8.1.51","journal-title":"Electrolyte Blood Press"},{"issue":"2","key":"2480_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1378\/chest.103.2.601","volume":"103","author":"M Sonnenblick","year":"1993","unstructured":"Sonnenblick M, Friedlander Y, Rosin AJ (1993) Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 103(2):601\u2013606","journal-title":"Chest"},{"issue":"1","key":"2480_CR33","first-page":"1","volume":"39","author":"AM Ramos-Levi","year":"2014","unstructured":"Ramos-Levi AM, Duran Rodriguez-Hervada A, Mendez-Bailon M, Marco-Martinez J (2014) Drug-induced hyponatremia: an updated review. Minerva Endocrinol 39(1):1\u201312","journal-title":"Minerva Endocrinol"},{"issue":"1","key":"2480_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","volume":"52","author":"G Liamis","year":"2008","unstructured":"Liamis G, Milionis H, Elisaf M (2008) A review of drug-induced hyponatremia. Am J Kidney Dis 52(1):144\u2013153. \n                    https:\/\/doi.org\/10.1053\/j.ajkd.2008.03.004","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2480_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12872-016-0425-x","volume":"16","author":"NM Berbenetz","year":"2016","unstructured":"Berbenetz NM, Mrkobrada M (2016) Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis. BMC Cardiovasc Disord 16(1):246. \n                    https:\/\/doi.org\/10.1186\/s12872-016-0425-x","journal-title":"BMC Cardiovasc Disord"},{"key":"2480_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.phrs.2017.01.025","volume":"119","author":"P Giosia Di","year":"2017","unstructured":"Di Giosia P, Passacquale G, Petrarca M, Giorgini P, Marra AM, Ferro A (2017) Gender differences in cardiovascular prophylaxis: focus on antiplatelet treatment. Pharmacol Res 119:36\u201347. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2017.01.025","journal-title":"Pharmacol Res"},{"issue":"8","key":"2480_CR37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/jhh.2010.86","volume":"25","author":"M Qvarnstrom","year":"2011","unstructured":"Qvarnstrom M, Wettermark B, Ljungman C, Zarrinkoub R, Hasselstrom J, Manhem K, Sundstrom A, Kahan T (2011) Antihypertensive treatment and control in a large primary care population of 21 167 patients. J Hum Hypertens 25(8):484\u2013491. \n                    https:\/\/doi.org\/10.1038\/jhh.2010.86","journal-title":"J Hum Hypertens"},{"issue":"11","key":"2480_CR38","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/eurheartj\/ehr045","volume":"32","author":"J Redon","year":"2011","unstructured":"Redon J, Olsen MH, Cooper RS, Zurriaga O, Martinez-Beneito MA, Laurent S, Cifkova R, Coca A, Mancia G (2011) Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J 32(11):1424\u20131431. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehr045","journal-title":"Eur Heart J"},{"issue":"10","key":"2480_CR39","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1097\/00004872-199816100-00021","volume":"16","author":"OH Klungel","year":"1998","unstructured":"Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A (1998) Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension. J Hypertens 16(10):1545\u20131553","journal-title":"J Hypertens"},{"issue":"40","key":"2480_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004908","volume":"95","author":"M Qvarnstrom","year":"2016","unstructured":"Qvarnstrom M, Kahan T, Kieler H, Brandt L, Hasselstrom J, Bostrom KB, Manhem K, Hjerpe P, Wettermark B (2016) Persistence to antihypertensive drug classes: a cohort study using the Swedish primary care cardiovascular database (SPCCD). Medicine 95(40):e4908. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000004908","journal-title":"Medicine"},{"issue":"7","key":"2480_CR41","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/ajh.2008.185","volume":"21","author":"Q Gu","year":"2008","unstructured":"Gu Q, Burt VL, Paulose-Ram R, Dillon CF (2008) Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Am J Hypertens 21(7):789\u2013798. \n                    https:\/\/doi.org\/10.1038\/ajh.2008.185","journal-title":"Am J Hypertens"},{"issue":"12","key":"2480_CR42","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jash.2014.08.015","volume":"8","author":"C Ljungman","year":"2014","unstructured":"Ljungman C, Kahan T, Schioler L, Hjerpe P, Hasselstrom J, Wettermark B, Bostrom KB, Manhem K (2014) Gender differences in antihypertensive drug treatment: results from the Swedish primary care cardiovascular database (SPCCD). J Am Soc Hypertens 8(12):882\u2013890. \n                    https:\/\/doi.org\/10.1016\/j.jash.2014.08.015","journal-title":"J Am Soc Hypertens"},{"issue":"6","key":"2480_CR43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/jhh.2014.100","volume":"29","author":"C Ljungman","year":"2015","unstructured":"Ljungman C, Kahan T, Schioler L, Hjerpe P, Wettermark B, Bostrom KB, Manhem K (2015) Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish primary care cardiovascular database (SPCCD). J Hum Hypertens 29(6):385\u2013393. \n                    https:\/\/doi.org\/10.1038\/jhh.2014.100","journal-title":"J Hum Hypertens"},{"key":"2480_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev.pu.16.050195.000425","volume":"16","author":"H Morgenstern","year":"1995","unstructured":"Morgenstern H (1995) Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health 16:61\u201381. \n                    https:\/\/doi.org\/10.1146\/annurev.pu.16.050195.000425","journal-title":"Annu Rev Public Health"},{"issue":"5","key":"2480_CR45","first-page":"1180","volume":"28","author":"M Lindquist","year":"2001","unstructured":"Lindquist M, Edwards IR (2001) The WHO Programme for international drug monitoring, its database, and the technical support of the Uppsala monitoring center. J Rheumatol 28(5):1180\u20131187","journal-title":"J Rheumatol"},{"key":"2480_CR46","unstructured":"Strom BL, Kimmel SE, Hennessy S (eds) (2011) Pharmacoepidemiology, 5th edn. Wiley, Hoboken, p 976"},{"issue":"6","key":"2480_CR47","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1023\/A:1007629920752","volume":"16","author":"KH Ladwig","year":"2000","unstructured":"Ladwig KH, Marten-Mittag B, Formanek B, Dammann G (2000) Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol 16(6):511\u2013518","journal-title":"Eur J Epidemiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2480-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T19:05:19Z","timestamp":1558897519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2480-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,27]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2480"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2480-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,27]]},"assertion":[{"value":"19 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}